n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, April 26th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Li3 Energy, Inc. (LIEG)

TopPennyStockMovers, Streetwise Reports, Ceocast News, FeedBlitz, Stockhouse, StockGuru, Pumps and Dumps, and PennyTrader Publisher reported previously on Li3 Energy, Inc. (LIEG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Li3 Energy, Inc. is an exploration stage company in the lithium mining and energy sector. It is working to acquire, develop, as well as commercialize a considerable portfolio of lithium brine deposits in the Americas. The Company has its interest in the Maricunga project. Li3 Energy has its corporate headquarters in Santiago, Chile.

Li3 Energy has an advanced exploration stage lithium and potassium project within the Salar de Maricunga. This is the second largest lithium bearing salt brine deposit in Chile. The Salar de Maricunga is in Region III (Atacama region) of northern Chile at an elevation of about 3,750m.

With its interest in the Maricunga project, together with the completion of the NI 43–101 Compliant Measured Resource Report and the Cocina acquisition, Li3’ Energy has four main goals. These are:

  • To advance the Maricunga project to the Feasibility Stage.
  • To support the worldwide implementation of clean and green energy initiatives.
  • To meet increasing lithium market demand.
  • To become a mid-tier, low cost supplier of lithium, potassium nitrate, iodine and other strategic minerals, serving worldwide clients in the energy, fertilizer, and specialty chemical industries.

Li3 Energy is concentrating on further exploring, developing, and commercializing its flagship "Maricunga Project". This project comprises two adjacent properties:  60 percent controlling interest in SLM Litio 1-6 (1,438 hectares); and the Cocina Mining Concessions (450 hectares) acquired in April 2013.

The Company has a strategic partnership with POSCO Canada Ltd. Li3 will continue its development of the Maricunga Project in Chile, together with a local strategic partner who will bankroll the project through to the permitting stage. Through POSCO, Li3 has been evaluating the use of advanced process technologies, which may further improve upon the economics and shorten the commercial production timeline of the Maricunga Project.

In September 2016, Li3 Energy advised that the legal and technical due diligence concerning the Maricunga Joint Venture (JV) between Lithium Power International Limited (LPI) and Minera Salar Blanco SpA (MSB) was satisfactorily completed. LPI entered into a binding and exclusive agreement with Chilean-based MSB for the exploration and development of the high-grade Maricunga lithium brine project in Chile, via the formation of new JV entity NewCo. The resulting ownership structure of NewCo is LPI 50 percent, MSB 32.3 percent, and Li3 Energy 17.7 percent, with MSB and Li3 free-carried until the completion of a Definitive Feasibility Study in late 2018.

In January of this year, Li3 Energy announced, with Bearing Resources Ltd., that on January 27, 2017 they entered into an agreement and plan of merger under which Bearing has agreed to acquire Li3. With this Agreement, a newly‐formed wholly-owned subsidiary of Bearing will merge with and into Li3 Energy. Li3 will survive the Merger as a wholly-owned subsidiary of Bearing Resources.

At the effective time of the Merger, each share of Li3 Energy common stock will be converted into the right to receive common shares of Bearing Resources based upon an aggregate of 16 million Bearing common shares issuable for the Li3 common stock.

Li3 Energy, Inc. (LIEG), closed Wednesday's trading session at $0.0206, down 11.97%, on 227,389 volume with 12 trades. The average volume for the last 60 days is 373,225 and the stock's 52-week low/high is $0.008/$0.055.

Integrated BioPharma, Inc. (INBP)

Wall Street Mover, Zacks, The Stock Psycho, StockMister, OTCPicks, HotShotStocks, Top Gun, and AllPennyStocks reported on Integrated BioPharma, Inc. (INBP), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Integrated BioPharma, Inc. engages chiefly in the manufacture, distribution, marketing, and sales of vitamins, nutritional supplements, and herbal products. Established in 1979, the Company’s customers are primarily in the U.S., Luxembourg, and Canada. Integrated BioPharma develops, manufactures, and distributes, internationally, more than 130 products. The Company does so via a number of wholly-owned subsidiaries.  Integrated BioPharma previously went by the name Integrated Health Technologies, Inc. The Company has its headquarters in Hillside, New Jersey.

Integrated Biopharma’s companies include AgroLabs, Inc., Chem International, IHT Health Products, Inc., Manhattan Drug Company, and Vitamin Factory. Integrated BioPharma operates through three segments. These are Contract Manufacturing, Branded Proprietary Products, and Other Nutraceutical Businesses.

AgroLabs manufactures and markets healthful nutritional products under the Naturally Noni, Naturally Pomegranate, Naturally Aloe, and Naturally Mangosteen brands. In addition, AgroLabs distributes around the world, in Canada, Germany, Japan, Korea, Mexico, Taiwan and the United Kingdom (UK). Integrated BioPharma’s Chem International offers a wide array of Roche Vitamins' food and cosmetic products.

Furthermore, Integrated BioPharma’s Vitamin Factory sells nutritional supplements directly to the consumer via mail order catalogs and over the Internet. Vitamin Factory’s product categories are dietary supplements, liquid items, sports supplements, as well as skincare supplements.

The Company’s Manhattan Drug Company provides vitamins and nutritional formulations. It involves in the manufacturing of tablets, capsules, or blends; packaging and labeling in bulk; help in product registration globally, and distribution of finished product. Moreover, Manhattan Drug engages in analytical and microbiological testing through its in-house laboratories.

Integrated Biopharma’s IHT Health Products sells and distributes fine chemicals. These include science-based proprietary products and value added formulations. IHT sells and distributes these to the nutritional, pharmaceutical, food, and cosmetic industries.

IHT products include vitamins, amino acids, herbal extracts, Over-the-Counter (OTC) pharmaceuticals, excipients, and innovative patented products. IHT Health Products has established strategic marketing alliances with varied research-based companies that have developed patented products unique to the industry.

Integrated Biopharma’s Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Company’s Branded Proprietary Products segment distributes healthful nutritional products for sale by way of mass market, grocery, drug, and vitamin retailers.

The Other Nutraceutical Businesses segment sells private label vitamin and nutritional supplement products, and healthful nutritional products via the Internet. It also distributes fine natural botanicals, including multi minerals, and raw materials. Also, this segment provides warehousing and fulfilment services.

Integrated BioPharma, Inc. (INBP), closed Wednesday's trading session at $0.203099, up 6.89%, on 1,250 volume with 4 trades. The average volume for the last 60 days is 9,826 and the stock's 52-week low/high is $0.04/$0.34.

BioLargo, Inc. (BLGO)

Stock News Now, Promotion Stock Secrets, Equities, SECFilings, TopPennyStockMovers, SmallCapVoice, Tiny Gems, FeedBlitz, and Penny Sleuth reported on BioLargo, Inc. (BLGO), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

BioLargo, Inc. delivers technology-based products that help solve some of the world's most important problems that threaten water, food, agriculture, healthcare and energy. The Company’s subsidiary is BioLargo Water, Inc.  BioLargo Water showcases the Advanced Oxidation Systems, including its AOS Filter. This is a product in development specifically designed to eliminate common, troublesome, and toxic contaminants in water in a fraction of the time and cost of present technologies. BioLargo is headquartered in Westminster, California.

The BioLargo® AOS Filter is the Company’s its featured AOS Filter system. It facilitates ongoing and scalable treatment with maximum efficiency employing GRAS components to convert contaminates to H2O and CO2.  It destroys hard to get contaminates and disinfects quickly and completely.

The BioLargo® AOS Filter is complementary with many filter systems. The BioLargo® AOS Filter extends the life of filtration systems, reduces corrosion, and conserves chemistry. BioLargo’s Canadian subsidiary, BioLargo Water, Inc. started a prototype development project for its AOS Filter technology.  

BioLargo owns a 50 percent interest in the Isan System. This system was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project.  In addition, BioLargo’s subsidiary, Odor-No-More, Inc., features award-winning products serving the pet, equine, military supply, and consumer markets. This includes the Nature's Best Solution® and Deodorall® brands. In addition, BioLargo’s subsidiary, Clyra Medical Technologies, Inc., concentrates on advanced wound care management.

BioLargo, via its commercial partner Clarion Water, obtained United States Environmental Protection Agency (EPA) registration for the use of aqueous iodine in poultry applications. The registration for poultry is a major milestone in the commercialization of a full set of biosecurity solutions targeted at lessening the risk of avian flu and other common pathogens

 BioLargo’s licensee, Clarion Water, received approval from the EPA for its aqueous iodine product, IoMax™, for sanitation of poultry drinking water. IoMax™ is supplied through the patented iSAN™ delivery system. This system accurately doses aqueous iodine into water systems. The iSAN system is licensed by Clarion from BioLargo and its joint venture partner Peter Holdings Ltd.

Recently, BioLargo announced that Mr. Mark Lambert joined its team as a Strategic Advisor to help develop and refine the Company's commercialization plan for its innovative Advanced Oxidation System within the water industry. Mr. Lambert has more than 25 years of experience as a senior level executive with wide-ranging experience in the water, renewable energy, and environmental services industries.

He has a strong track record of success in the management of successful organizations. Mr. Lambert's expertise includes P&L and operations management, sales and marketing management, mergers and acquisitions (M&A’s), strategic planning, growth capital, and transactional support.

BioLargo, Inc. (BLGO), closed Wednesday's trading session at $0.4999, up 9.84%, on 134,789 volume with 44 trades. The average volume for the last 60 days is 73,059 and the stock's 52-week low/high is $0.3101/$1.0777.

Eco Tek 360, Inc. (ECTX)

We are reporting on Eco Tek 360, Inc. (ECTX) today, here at the QualityStocks Daily Newsletter.

Established in 2004, Eco Tek 360, Inc. offers contemporary, sustainably sourced casual clothing. Its patented green technology allows it to provide sustainable uniforms. The Company previously went by the name Global Fashion Technologies, Inc. It changed its name to EcoTek360, Inc. in January of this year. Eco Tek 360 is headquartered in Somerville, New Jersey.

The Company centers on providing branded fabrics, apparel, as well as uniforms to the corporate, hotel, hospital, and military markets. Eco Tek 360’s state-of-the-art green technology permits it to collect and rejuvenate a customer’s used uniforms into new uniforms. Eco Tek 360 rejuvenates old uniforms and recovers the fiber to spin yarn, make fabric, and cut and sew new uniforms in its U.S. based facility.

The Company’s quality process is integrated from the collection of customers’ old uniforms via delivery to them from its New Jersey warehouse. Its in-house capabilities ensure versatility, world-class design, and responsiveness to support small batch construction for specialty products, unique sizing, and personalization with fast turn times.

In February, Eco Tek 360 announced that Mr. Paul Serbiak immediately assumed the role of Chief Executive Officer at Eco Tek 360. Mr. Serbiak is a highly-qualified manager. He is the inventor of greater than 30 patented products and technologies.

In addition, Mr. Serbiak is a Chemical Engineer as well as a highly-experienced manager. He held leadership positions at Procter & Gamble, Kimberly Clark, and Johnson & Johnson. His career includes serving as a Global Vice President at Johnson and Johnson and also senior strategic roles at Procter & Gamble and Kimberly Clark.

In March, Eco Tek 360’s President, Mr. Chris H Giordano stated. “We are pleased to announce to our shareholders that Mr. Simon Graj will now serve as Co-Chairman along with myself to help guide our Company into the future. Simon is the Co-Founder of Graj and Gustavsen one of the world’s leading brand consultants.”

Simon Graj is considered a true pioneer in the world of branding and retail. He founded his firm, Graj and Gustavsen, in 1990. Before G+G, Mr. Graj’s professional career spanned two decades as a retail innovator in leadership positions working in all aspects of the industry.

Eco Tek 360, Inc. (ECTX), closed Wednesday's trading session at $0.14, down 36.36%, on 72,400 volume with 16 trades. The average volume for the last 60 days is 2,372 and the stock's 52-week low/high is $0.135/$0.56.

TimefireVR, Inc. (TFVR)

We are highlighting TimefireVR, Inc. (TFVR) today, here at the QualityStocks Daily Newsletter.

TimefireVR, Inc. is a software company with a virtual reality platform for immersive, interactive, and social experiential learning. The Company established in early 2014 to develop a virtual reality application platform, Hypatia, built on pillars of social interaction, commerce, cultural immersion, and entertainment.

On September 14, 2016, EnergyTek Corp. announced that it merged with Timefire LLC. The Company then changed its name to TimefireVR, Inc.  A Technology Company, TimefireVR is based in Scottsdale, Arizona. The Company lists on the OTC Markets’ OTCQB. EnergyTek is the parent of TimefireVR.

Hypatia is a curated virtual reality destination metaverse of vast scale. Hypatia is influenced from some of the most visited cities in the world. TimefireVR's VR platform application provides an environment for cooperative participation and experiential learning in a safe environment. The Company’s goal is to create the first virtual reality city.

With Hypatia, one can socialize, talking via text or audio. One can also shop, watch videos, concerts, and also plays. With Hypatia, a user can create and customize the world about them. Moreover, a user can travel to real cities and fantasy destinations.

In January 2017, TimefireVR announced entering into an exclusive strategic alliance with SHEnetics. This allows TimefireVR to offer the users of its VR products the capability to use intelligent conversational voice technology for exploration and information acquisition while remaining immersed in VR. SHEnetics is a cloud based Artificial Intelligence (AI) platform.

In March, TimefireVR announced the alpha launch of its virtual reality platform, Hypatia. The Alpha launch will be a controlled testing environment of about 200 users from all over the U.S. The launch will promote the platform’s social capabilities and represent the first time virtual interaction between users sitting in multiple locations takes place on this scale.

Additionally, in March, TimefireVR announced an agreement with Solid State Networks of Phoenix, Arizona to implement DIRECT 5 for Release Automation to speed up last-mile deployment of Hypatia in Alpha.

TimefireVR, Inc. (TFVR), closed Wednesday's trading session at $0.21, up 3.45%, on 14,580 volume with 14 trades. The average volume for the last 60 days is 54,675 and the stock's 52-week low/high is $0.202/$2.50.

graphic

The QualityStocks
Company Corner

graphic
graphic

CD International Enterprises, Inc. (CDII)

The QualityStocks Daily Newsletter would like to spotlight CD International Enterprises, Inc. (CDII). Today, CD International Enterprises, Inc. closed trading at $0.0101, up 2.02%, on 3,371,702 volume with 116 trades. The stock’s average daily volume over the past 60 days is 1,282,504 and its 52-week low/high is $0.0001/$40.00.

CD International Enterprises, Inc. a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, today announced that it has entered into a wholesale distribution agreement with a U.S.-based manufacturer of cannabidiol(CBD)-based products. Under the agreement, CD International will market CBD products to the Chinese-speaking population and CD International will purchase CBD products at a wholesale price. The most popular products include Chill and Relax Gummies, a tasty selection of more than 200 flavored CBD Hemp Oils, Blue CBD Crystals Isolate, Relax Extreme CBD collection, CBD Shots and quality Vape Additives.

CD International Enterprises, Inc. (CDII) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.CD International Enterprises, Inc., CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

CD International Enterprises, Inc. Blog

CD International Enterprises, Inc. News:

CD International Enterprises Enters a Wholesale Distribution Agreement Including Products for Relaxation and Flavored Hemp Oils

CD International Enterprises Enters Partnership Agent Sales Agreement with NutraFuels, Inc.

CD International Enterprises Launches Newly Formed Subsidiary and Online Store to Distribute Cannabidiol (CBD)-Based Products in Chinese-Speaking Communities

Players Network, Inc. (PNTV)

The QualityStocks Daily Newsletter would like to spotlight Players Network, Inc. (PNTV). Today, Players Network, Inc. closed trading at $0.053985, off by 0.03%, on 2,247,939 volume with 112 trades. The stock’s average daily volume over the past 60 days is 1,640,068, and its 52-week low/high is $0.0022/$0.0548.

Players Network, Inc. issued an update on its WeedTV.com platform. The platform has been internally tested and the company said it expects it to have a beta launch in the near future. WeedTV.com will enable any business in the medicinal marijuana industry to create a personalized media network online. In the letter, the company explains that revenue will be generated through licensing of the software that creates and controls each of these personalized media networks. To view the full press release, visit: http://nnw.fm/cbX7o

Players Network, Inc. (PNTV) is a diversified holding company operating in marijuana and media. PNTV owns 86% of Green Leaf Farms Holdings, LLC (Green Leaf Farms) which has Nevada state-issued cultivation and production license(s). The cultivation license enables Green Leaf Farms to grow marijuana and the production license enables them to create extracts which are used for cartridges, oils and edibles. WeedTV.com is a wholly owned subsidiary which is developing the ultimate resource for the marijuana lifestyle. PNTV has been a fully reporting, publicly traded company since 1998.

Green Leaf Farms Holdings, LLC (Green Leaf)

Green Leaf produces medical and recreational cannabis products. Revenues are generated by selling their cannabis products to licensed dispensaries throughout Nevada.

Their mission is to produce the highest quality and safest pharmaceutical-grade cannabis to all levels of consumers. They utilize the most efficient cultivation methods in order to lower expenses for consumers and to maximize returns for investors.

They are a privately held company with a unique business model as they are one of only a few companies who have been granted 2 (two) Medical Marijuana Establishment (MME) licenses in Nevada; Cultivation and Production.

Their Cultivation License enables them to grow cannabis which will produce flower. Their Production License enables them to process flower (cannabis) and cannabis byproducts into extremely pure concentrates, extracts, and oils which are used in medicine, cartridges and edibles. Green Leaf has both acquired and developed proprietary cannabis strains and will continue to be committed to cannabis research and development.

Green Leaf is located in North Las Vegas, Nevada on 2.3 acres in a state-of-the-art 26,000 sq. ft. facility. They have a seasoned team of professional growers and operators to manage the facility with proven best practices to ensure they have the highest quality products available.

WeedTV.com

WeedTV.Com is a niche social network and lifestyle channel destination for the marijuana industry. They are developing the "go-to" source for information, entertainment, products and services for people who relate to the marijuana lifestyle and an active social community. WeedTV.com features daily stories sourced by WeedTV.com correspondents and contributors from around the world.

Programming includes, political news, business news on the industry, financial analysis from industry experts, growing tips, cooking tips, the "Weed101" section, medical applications/issues, lifestyle features, and entertainment specials.

WeedTV.com's first original series is titled "High Stakes." High Stakes was developed by Michael Berk, the company's Chief Creative Officer and creator of one of the most popular cable series of all time, Baywatch. High Stakes is docu-series that follows the team at Green Leaf Farms as they build their facility and launch their marijuana business.

By leveraging media, WeedTV.com builds long-term brand equity and connects consumers to businesses. This is accomplished through fresh and relevant content such as professionally produced branded television segments, user-generated videos, blogs, editorials, tweets (twitter), photos, special offers, events and custom-designed contests to engage both consumers and businesses with their brands and services.

Marijuana and Media Strategy

While developing WeedTV.com, the PNTV team realized they could implement a vertical strategy to utilize their media platform (WeedTV.com) to drive business and awareness to their cannabis products (Green Leaf Farms). Through the audience and reach of WeedTV.com, they will build brand value and cross market their own marijuana products, as well as generate revenues by marketing other companies' products and services. Disclaimer

Players Network, Inc. Company Blog

Players Network, Inc. News:

NetworkNewsBreaks – Player’s Network, Inc. (PNTV) Issues Update on WeedTV.com, Plans to Launch Beta

Player's Network CEO Provides 1Q Shareholder Update, Outlook

Players Network (OTCQB: PNTV) Featured on MoneyTV with Donald Baillargeon, 2/17

InMed Pharmaceuticals, Inc. (IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.52, up 13.04%, on 2,305,256 volume with 953 trades. The stock’s average daily volume over the past 60 days is 1,134,763, and its 52-week low/high is $0.05/$0.72.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Pharmaceuticals' Unique Approach Featured in Forbes -- CFN Media

InMed's Exceptional Management Team Executes Ambitious Plan -- CFN Media

NetworkNewsWire Announces Publication of Discussion on the R&D of Cannabinoids for Medical Use

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.049, up 4.26%, on 2,391,507 volume with 177 trades. The stock’s average daily volume over the past 60 days is 7,832,089, and its 52-week low/high is $0.0056/$0.142.

Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.

SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.

SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.

As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

NetworkNewsWire Announces Publication on Various Companies Involved in Booming Cannabis Industry, Including

SinglePoint Draws Attention as Near-term Catalysts Approach -- CFN Media

NetworkNewsWire Announces Publication Discussing Public Support of Legalized Marijuana, Key Industry Players

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $1.16, up 2.65%, on 22,898 volume with 31 trades. The stock’s average daily volume over the past 60 days is 99,898 and its 52-week low/high is $0.12/$2.75.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com Blog

ChineseInvestors.com News:

ChineseInvestors.com, Inc. Announces 3Q Financial Results, Posts Nearly 100% YoY Increase, Expects Hemp Products to Generate Substantial Revenues in 2018

ChineseInvestors.com to Attend 'Invest 2017' Exhibition in Stuttgart, Germany

ChineseInvestors.com Announces Investment in Breakwater MB, LLC a Cannabis-Focused Investment and Consulting Company

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

StockMarketWatch
(MTBC) +179.18%

2.

Trader Power News
(SAJA) +42.86%

3.

BullFreak
(SNET) +39.01%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251